APA (7th ed.) Citation

Thome, A. D., Thonhoff, J. R., Wang, J., Berman, H., Grossman, F., & Appel, S. H. (2025). Glucagon-like peptide-1 agonism in combination with low-dose interleukin 2 enhances regulatory T cell suppressive function in vitro. NeuroImmune Pharmacology & Therapeutics, 4(2), 253. https://doi.org/10.1515/nipt-2025-0001

Chicago Style (17th ed.) Citation

Thome, Aaron D., Jason R. Thonhoff, Jinghong Wang, Howard Berman, Fred Grossman, and Stanley H. Appel. "Glucagon-like Peptide-1 Agonism in Combination with Low-dose Interleukin 2 Enhances Regulatory T Cell Suppressive Function in Vitro." NeuroImmune Pharmacology & Therapeutics 4, no. 2 (2025): 253. https://doi.org/10.1515/nipt-2025-0001.

MLA (9th ed.) Citation

Thome, Aaron D., et al. "Glucagon-like Peptide-1 Agonism in Combination with Low-dose Interleukin 2 Enhances Regulatory T Cell Suppressive Function in Vitro." NeuroImmune Pharmacology & Therapeutics, vol. 4, no. 2, 2025, p. 253, https://doi.org/10.1515/nipt-2025-0001.